„Luteolin Offers Novel Therapeutic Regimen in Rotenone-Induced Parkinson Disease via Modulation of TNF-α FXMRP Serotonin Tyrosine Hydroxylase Signaling Pathway”. Nigerian Journal of Physiological Sciences, köt. 40, sz. 2, 2025. december, o. 251-62, https://doi.org/10.54548/.